News
Amarin autoimmune disease drug candidate meets study goals, confirming prior results Yahoo/AP
View ArticleStudy: Deal terms getting richer as pharmas stockpile antibody tech
Study: Deal terms getting richer as pharmas stockpile antibody tech Fierce Biotech
View ArticleKaro Bio Signs Research Pact With Pfizer for Autoimmune Diseases
Karo Bio Signs Research Pact With Pfizer for Autoimmune Diseases Bloomberg
View ArticleCoronado Biosciences: 2013 - Year Of The Worm
Coronado Biosciences: 2013 - Year Of The Worm Seeking Alpha
View ArticleArena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for...
Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases Yahoo
View ArticleQuestcor Surges After Acquiring Rights to Novartis Drug
Questcor Surges After Acquiring Rights to Novartis Drug Bloomberg
View ArticlePfizer nabs autoimmune disease drug rights for $25M upfront
Pfizer nabs autoimmune disease drug rights for $25M upfront Fierce Biotech
View ArticleIdera Pharmaceuticals Presents a Promising Opportunity
Idera Pharmaceuticals Presents a Promising Opportunity Wall St Cheat Sheet
View ArticleJ&J Innovation launches a discovery pact with fledgling upstart Scholar Rock
J&J Innovation launches a discovery pact with fledgling upstart Scholar Rock Fierce Biotech
View ArticleIdera: A Compelling Biotech Pick For March
Idera: A Compelling Biotech Pick For March Seeking Alpha
View ArticleAstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints
AstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints The Fly on the Wall
View ArticleVirobay banks $8M to accelerate its treatments for pain, autoimmunity
Virobay banks $8M to accelerate its treatments for pain, autoimmunity Fierce Biotech
View Article
